Skip to main content

Cytek Biosciences, Inc.

CTKB
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
SEC CIK
0001831915

No open-market purchases or sales by Cytek Biosciences, Inc. insiders were filed in the last 90 days; 154 institutions reported holding it in 13F filings for Q2 2026, worth $361.0M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.

Q1 2023 vs. Q4 2022

How the institutions holding Cytek Biosciences, Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of CTKB: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders103102−1
Shares64.1M68.5M+4.45M (+7.0%)
Value$654.1M$629.6M−$24.5M (−3.7%)

New holders (16)

Institutions that held Cytek Biosciences, Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to CTKB in Q1 2023
InstitutionSharesValue% of portfolio
Wellington Management Group LLP1,235,206$11.4M0.00%
Susquehanna International Group, LLP307,020$2.82M0.00%
Dimensional Fund Advisors LP163,537$1.50M0.00%
Dark Forest Capital Management LP137,838$1.27M0.30%
Tudor Investment Corp Et Al123,997$1.14M0.02%
ExodusPoint Capital Management, LP119,770$1.10M0.01%
Verition Fund Management LLC78,392$720.4K0.01%
Teachers Retirement System of the State of Kentucky69,682$640.0K0.01%
Royce & Associates LP44,414$408.2K0.00%
Zevenbergen Capital Investments LLC40,300$370.4K0.01%
Grandeur Peak Global Advisors, LLC33,131$304.5K0.02%
Victory Capital Management Inc28,714$263.9K0.00%
Prelude Capital Management, LLC18,172$167.0K0.01%
Dynamic Technology Lab Private Ltd13,581$125.0K0.01%
TCI Wealth Advisors, Inc.346$3.18K0.00%
Bogart Wealth, LLC24$2210.00%

Sold out (17)

Institutions that held Cytek Biosciences, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.